Literature DB >> 11306819

Assignment of TACSTD1 (alias TROP1, M4S1) to human chromosome 2p21 and refinement of mapping of TACSTD2 (alias TROP2, M1S1) to human chromosome 1p32 by in situ hybridization.

G Calabrese1, C Crescenzi, E Morizio, G Palka, E Guerra, S Alberti.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11306819     DOI: 10.1159/000056891

Source DB:  PubMed          Journal:  Cytogenet Cell Genet        ISSN: 0301-0171


× No keyword cloud information.
  18 in total

1.  siRNA targeting of Trop2 suppresses the proliferation and invasion of lung adenocarcinoma H460 cells.

Authors:  Xiao-Yan Gao; Ye-Han Zhu; Li-Xin Zhang; Hui-Yu Lu; Ai-Gui Jiang
Journal:  Exp Ther Med       Date:  2015-05-28       Impact factor: 2.447

Review 2.  The current status of tailor-made medicine with molecular biomarkers for patients with clear cell renal cell carcinoma.

Authors:  Sunao Shoji; Mayura Nakano; Haruhiro Sato; Xian Yang Tang; Yoshiyuki Robert Osamura; Toshiro Terachi; Toyoaki Uchida; Koichi Takeya
Journal:  Clin Exp Metastasis       Date:  2014-01       Impact factor: 5.150

3.  Trop2 gene: a novel target for cervical cancer treatment.

Authors:  Xiaoqi Liu; Siqi Li; Faping Yi
Journal:  J Cancer Res Clin Oncol       Date:  2014-05-10       Impact factor: 4.553

4.  EpCAM is overexpressed in gastric cancer and its downregulation suppresses proliferation of gastric cancer.

Authors:  Du Wenqi; Wang Li; Cao Shanshan; Chen Bei; Zhang Yafei; Bai Feihu; Liu Jie; Fan Daiming
Journal:  J Cancer Res Clin Oncol       Date:  2009-03-18       Impact factor: 4.553

5.  EpCAM: a potential antimetastatic target for gastric cancer.

Authors:  Wenqi Du; Hongzan Ji; Shanshan Cao; Li Wang; Feihu Bai; Jie Liu; Daiming Fan
Journal:  Dig Dis Sci       Date:  2009-11-26       Impact factor: 3.199

6.  Lunx is a superior molecular marker for detection of non-small cell lung cancer in peripheral blood [corrected].

Authors:  Michael Mitas; Loretta Hoover; Gerard Silvestri; Carolyn Reed; Mark Green; Andrew T Turrisi; Carol Sherman; Kaidi Mikhitarian; David J Cole; Mark I Block; William E Gillanders
Journal:  J Mol Diagn       Date:  2003-11       Impact factor: 5.568

7.  Ep-CAM expression in squamous cell carcinoma of the esophagus: a potential therapeutic target and prognostic marker.

Authors:  Nikolas H Stoecklein; Annika Siegmund; Peter Scheunemann; Andreas M Luebke; Andreas Erbersdobler; Pablo E Verde; Claus F Eisenberger; Matthias Peiper; Alexander Rehders; Jan Schulte Am Esch; Wolfram Trudo Knoefel; Stefan B Hosch
Journal:  BMC Cancer       Date:  2006-06-23       Impact factor: 4.430

8.  A novel TACSTD2 mutation identified in two Chinese brothers with gelatinous drop-like corneal dystrophy.

Authors:  Yang Jing; Chun Liu; Liya Wang
Journal:  Mol Vis       Date:  2009-08-14       Impact factor: 2.367

9.  mTrop1/Epcam knockout mice develop congenital tufting enteropathy through dysregulation of intestinal E-cadherin/β-catenin.

Authors:  Emanuela Guerra; Rossano Lattanzio; Rossana La Sorda; Francesca Dini; Gian Mario Tiboni; Mauro Piantelli; Saverio Alberti
Journal:  PLoS One       Date:  2012-11-28       Impact factor: 3.240

10.  Expression and clinical significance of the Trop-2 gene in advanced non-small cell lung carcinoma.

Authors:  Aigui Jiang; Xiaoyan Gao; Degeng Zhang; Lixin Zhang; Huiyu Lu
Journal:  Oncol Lett       Date:  2013-05-29       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.